Apply on Employer Site

BioNTech SE · 3 days ago

Director, Global Product Strategy - Lung Cancer Therapies

Berkeley Heights, NJ

Full-time

Onsite

Director/Executive

$168K/yr - $269K/yr

8+ years exp

BioNTech SE is seeking a strategic, science-driven leader to join their Global Product Strategy team as Director for Lung Cancer Portfolio. This role focuses on new product planning and early commercial strategy, requiring hands-on leadership and deep oncology market insight to influence the strategic direction of a high-priority solid tumor program.

Health Care

Responsibilities

Lead global commercial strategy development for the lung cancer portfolio, with a focus on indication prioritization, early positioning, and value-focused lifecycle strategy

Drive new product planning activities from preclinical/early clinical through registrational development, supporting strategic TPP shaping, unmet need assessment, competitive differentiation, and commercial viability

Partner cross-functionally with R&D, clinical development, translational research, regulatory, and medical affairs to embed commercial perspectives into key decisions

Lead or co-lead commercial input into early launch readiness planning, with emphasis on evidence strategy, access considerations, and strategic stakeholder engagement

Contribute to cross-functional governance processes, development strategy forums, and scenario planning efforts

Support external interactions where needed (e.g., advisory boards, co-development partners, select KOL discussions) in alignment with medical and development leadership

Work collaboratively across the internal team to ensure that the lung cancer portfolio is progressing in line with both scientific excellence and commercial ambition

Qualification

Oncology commercial strategyNew product planningLaunch readinessSolid tumors experienceEarly-stage commercializationOncology clinical trial designUS oncology landscapeCross-regional experienceScientific acumenNavigate ambiguityStrategic mindsetCollaboration skills

Required

A minimum of 8 years of relevant experience in oncology commercial strategy, new product planning, launch readiness, or asset strategy roles

Strong track record in solid tumors, ideally with direct or adjacent lung cancer experience

Significant experience in early-stage commercialization, including product concept shaping, indication assessment, and early launch strategy

Ability to partner effectively with R&D, including familiarity with oncology clinical trial design, regulatory pathways, and biomarker-driven development

Demonstrated understanding of the US oncology landscape and stakeholder needs; experience & understanding with EU and other major markets

Strong scientific acumen combined with a highly strategic mindset and the ability to navigate ambiguity in a pre-commercial environment

Experience working in global or cross-regional roles, ideally within biotech or fast-paced oncology-focused companies